🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 045396108 (prev. 922822101 )
- Market Cap
- Micro Cap
- IPO
- 12/17/2010 · $6.00/share
- Previous Symbol
- VTUS (changed 7/11/2014)
- Previous Name
- Ventrus Biosciences, Inc.
Business: Assembly Biosciences, Inc. is a development-stage specialty pharmaceutical company. The Company is focused on the development of late-stage and pre-clinical prescription drugs and biologics, for gastrointestinal disorders.
Notes: July 14, 2014 -- Ventrus Biosciences, Inc. (Nasdaq:VTUS) today announced that its stockholders have approved the issuance of common stock in connection with the merger between Ventrus and Assembly Pharmaceuticals, Inc. in an all-stock transaction. The merger was effective on July 11, 2014. Ventrus stockholders also approved a 1-for-5 reverse stock split and the change of the name of the company to Assembly Biosciences, Inc., both of which were effective on July 11, 2014. On Monday, July 14, 2014, the common stock of Assembly Biosciences, Inc. will begin trading under the ticker ASMB.
Company Contact
- CEO
- Jason Okazaki
- CFO
- Jason Okazaki
- Headquarters
- Two Tower Place, 7th Floor, South San Francisco, CA 94080
- Phone
- 833-509-4583
- Investor Relations
- Shannon Ryan · 415-738-2992 · sryan@assemblybio.com